To assess the efficacy and safety of telaprevir (TVR) in combination with pegylated interferon α‐2a (PEG‐IFNα‐2a) and ribavirin (RBV) for treatment‐naïve patients and relapsed patients compared to previous TVR‐based triple… Click to show full abstract
To assess the efficacy and safety of telaprevir (TVR) in combination with pegylated interferon α‐2a (PEG‐IFNα‐2a) and ribavirin (RBV) for treatment‐naïve patients and relapsed patients compared to previous TVR‐based triple therapy in Japan.
               
Click one of the above tabs to view related content.